Publications by authors named "Tito Fojo"

Claim this Profile
C
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinoma.
Maryam Safari, Luigi Scotto, Agnes Basseville, Thomas Litman, Haoran Xue, Tito Fojo

Drug Resist Updat· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From dimensions through dynamics to outcomes - lymph nodes and skin assessments predict CTCL outcomes.
Alexander Kaminsky, Lauren M Fahmy, Zaid Bilgrami, Hye Ryung Yang, Volkan Beylergil, Tito Fojo

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlights of ASCO 2025.
Brandon DaSilva, Alfred I Neugut, Tito Fojo, Susan E Bates

Oncologist· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer.
Harshraj Leuva, Mengxi Zhou, Benjamin A Teply, Yeun-Hee Anna Park, Carol Luhrs, Tito Fojo

JAMA Netw Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the Editor Regarding 'Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'.
Martin W Schoen, Tito Fojo

Adv Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why We Do Not Recommend That Women With Breast Cancer Receive Adjuvant Treatment With a CDK4/6 Inhibitor.
Ian F Tannock, Qamar J Khan, Tito Fojo

J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harvesting information from Kaplan-Meier plots: part 2-detecting informative censoring as the starting point for an in-depth analysis. Sotorasib plus panitumumab in colorectal cancer as an example.
Brandon DaSilva, Mengxi Zhou, Tito Fojo

Oncologist· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skimming the Median and the Problem of Exaggerated Survival Gains.
Tito Fojo, Susan Bates

JAMA Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for a reduction in number of cycles of immune checkpoint inhibitors.
Abdul-Hamid Bazarbachi, Nicola Magrini, Zeba Aziz, Tito Fojo

Lancet Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors.
Jacob K Jamison, Mengxi Zhou, Edward P Gelmann, Lyndon Luk, Susan E Bates, Tito Fojo

Oncologist· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of mitotane in the management of adrenocortical cancer.
Jaydira Del Rivero, Tobias Else, Julie Hallanger-Johnson, Katja Kiseljak-Vassiliades, Nitya Raj, Antonio Tito Fojo

Oncologist· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses.
Harshraj Leuva, Mengxi Zhou, Nader Jamaleddine, Mina Meseha, Izak Faiena, Tito Fojo

EBioMedicine· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotorasib in KRAS-Mutated Colorectal Cancer.
Tito Fojo

N Engl J Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma.
Maryam Safari, Luigi Scotto, Agnes Basseville, Thomas Litman, Haoran Xue, Tito Fojo

bioRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seminars in oncology 50th anniversary.
Tito Fojo

Semin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Exuberance on Equipoise in Oncology Clinical Trials: Sotorasib as Archetype.
Tito Fojo, Meredith LaRose, Susan E Bates

Oncologist· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The statistical significance revolution.
Alfred I Neugut, Tito Fojo

JNCI Cancer Spectr· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement.
David Taïeb, Svenja Nölting, Nancy D Perrier, Martin Fassnacht, Jorge A Carrasquillo, Tito Fojo

Nat Rev Endocrinol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons from withdrawn accelerated approvals in oncology.
George S Mellgard, Tito Fojo, Susan E Bates

Nat Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitotane and the myth of 14 mg/L.
Matthew I Ehrlich, Brian W Labadie, Susan E Bates, Tito Fojo

Lancet Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnic diversity in treatment response for colorectal cancer: proof of concept for radiomics-driven enrichment trials.
Laurent Dercle, Melissa Yang, Mithat Gönen, Jessica Flynn, Chaya S Moskowitz, Tito Fojo

Eur Radiol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Waiting for ASCO to "Walk the Walk".
Tito Fojo

Oncologist· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment.
Eunhyeong Lee, Sophie O'Keefe, Alessandra Leong, Ha-Ram Park, Janani Varadarajan, Tito Fojo

J Clin Invest· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Therapeutic Strategies Exploiting the Unique Properties of Neuroendocrine Neoplasms.
Maryam Safari, Luigi Scotto, Thomas Litman, Lubov A Petrukhin, Hu Zhu, Tito Fojo

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Journeys to Failure that Litter the Path to Developing New Cancer Therapeutics.
Tito Fojo

JAMA Netw Open· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis